Linea Guida della Associazione dei Medici Diabetologi (AMD), della Società Italiana di Diabetologia (SID) e della Società Italiana di Endocrinologia e Diabetologia Pediatrica (SIEDP)
La terapia del diabete mellito di tipo 1
Leggi
Breaking news
GLP-1RAs for ischemic stroke prevention in patients with type 2 diabetes without established atherosclerotic cardiovascular
Yang YS, Chen HH, Huang CN, et al.
Diabetes Care. 2022;dc211285
Leggi
When therapeutic drugs lead to diabetes
Fève B, Scheen AJ
Diabetologia. Pub. online 4 March 2022.
Leggi
Which scale is more useful to detect diabetic neuropathic pain? A cross-sectional study
Ünlütürk Z, Öztekin SNS, Alkan H, et al.
BMC Endocr Disord. 2022;22(1):56.
Leggi
Clinical insights into management options for recurrent type 2 diabetes and cardiovascular risk after metabolic-bariatric surgery
Lupoli R, Lembo E, Giosuè A, et al.
NMCD. Pub. online 9 March 2022.
Leggi
Association between real-time continuous glucose monitor use and diabetes-related medical costs for patients with type 2 diabetes
Norman G, Paudel ML, Parkin CG, et al.
Diabetes Technol Ther. Pub. online 1 Mar 2022.
Leggi
Feasibility of closed-loop insulin delivery with a pregnancy specific zone model predictive control algorithm
Ozaslan B, Levy C, Kudva YC, et al.
Diabetes Technol Ther. Pub. online 1 Mar 2022.
Leggi
Clinical outcomes with metformin and sulfonylurea therapies among patients with heart failure and diabetes
Khan MS, Solomon N, DeVore AD, et al.
JACC Heart Fail. 2022;10(3):198-210.
Leggi
Prevalence trends of diabetes subgroups in the United States: a data-driven analysis spanning three decades from NHANES (1988-2018)
Antonio-Villa NE, Fernández-Chirino L, Vargas-Vázquez A, et al.
J Clin Endocrinol Metab. 2022;107(3):735-742.
Leggi
Evaluation of accuracy and safety of the next-generation up to 180-day long-term implantable eversense continuous glucose monitoring system: the PROMISE study
Garg SK, Liljenquist D, Bode B, et al.
Diabetes Technol Ther. 2022;24(2):84-92.
Leggi